Bard Decision Unlikely To Deter DoJ From Seeking Criminal Prosecution
This article was originally published in The Gray Sheet
Executive Summary
The Justice Department will continue to prosecute medical device companies and executives suspected of intentionally violating FDA regulations, despite the department's disappointment with the outcome of its case against C.R. Bard.